Summary: Iconovo has revealed that it has received a grant of $883,800 from the Bill…
Monthly Archives
July 2022
-
-
Global Market
MHRA Grants Marketing Authorisation for Global Blood Therapeutics’s Oxbryta (Voxelotor)
by adminSummary: Voxelotor is the first medicine in Britain to directly inhibit sickle haemoglobin polymerisation Global…
-
AstraZenecaMerger / Acquisition
AstraZeneca to Acquire TeneoTwo and its Clinical-stage T-cell Engager TNB-486
by adminSummary : AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I…
-
BayerMerger / Acquisition
Bayer to Sell Men’s Health Product Nebido™ to Grünenthal for 500 Million Euro.
by adminSummary : Bayer and Grünenthal have entered into a definitive agreement regarding the sale of…
-
ChemIntelligenceGlobal Market
Boehringer Ingelheim, Evotec and BioMérieux Launch Aurobac, a joint venture to fight Antimicrobial Resistance
by adminSummary : Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE…
-
ChemIntelligence
New ISO Candidate July 2022 Update – Japanese Nissan Chemical: Iptriazopyrid – New Herbicide Candidate Published
by adminJuly 20, 2022 – Japanese Nissan Chemical: Iptriazopyrid – New Herbicide Candidate Published. The Japanese…
-
U.S FDA
FDA Approved ZONISADE™ (Zonisamide Oral Suspension) of AZURITY PHARMACEUTICALS, INC.
by adminSummary : The first and only FDA-approved zonisamide oral liquid formulation 100 mg/5 mL as…
-
U.S FDA
The U.S. FDA has Approved Opzelura(Ruxolitinib) Cream by Incyte for the Treatment of Vitiligo.
by adminSynopsis : Opzelura is the first and only FDA-approved product for repigmentation in nonsegmental vitiligo…
-
Summary : GSK plc announced it has completed the acquisition of Sierra Oncology, Inc. (Sierra…
-
Summary : Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP), a specialty pharmaceutical company developing…
Newer Posts